Finance

Stifel maintains Buy on Denali Therapeutics stock, $37 target

https://www.investing.com/news/analyst-ratings/stifel-maintains-buy-on-denali-therapeutics-stock-37-target-93CH-4065505 Investing.com

Raymond James maintains CRM stock Strong Buy, $375 target

https://www.investing.com/news/analyst-ratings/raymond-james-maintains-crm-stock-strong-buy-375-target-93CH-4065506 Investing.com

Cowen maintains buy on Compass Pathways, target $23

https://www.investing.com/news/analyst-ratings/cowen-maintains-buy-on-compass-pathways-target-23-93CH-4065458 Investing.com

Latest articles

spot_imgspot_img